Moreover, inhibition of indoleamine 2,3-dioxygenase-1, an enzyme that catalyzes the degradation of an essential amino acid tryptophan, suppresses tumor growth in a lymphocyte-dependent manner in immunocompetent but not immunocompromised mice bearing pancreatic tumors 63. This evidence concerns the gene IDO1 and pancreatic neoplasm.